TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Capital expenditures 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$501.0MFY2025 · since FY2016: $901.0M → $501.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $501.0M | +0.6% |
| FY2024 | $498.0M | -5.3% |
| FY2023 | $526.0M | -4.0% |
| FY2022 | $548.0M | -2.5% |
| FY2021 | $562.0M | -2.8% |
| FY2020 | $578.0M | +10.1% |
| FY2019 | $525.0M | -19.4% |
| FY2018 | $651.0M | -25.5% |
| FY2017 | $874.0M | -3.0% |
| FY2016 | $901.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice